Emerging Markets Outperform US and Europe: A Shift in Global Investment Trends?
Finance

Emerging Markets Outperform US and Europe: A Shift in Global Investment Trends?

authorBy Lisa Jing
DateMay 12, 2026
Read time2 min

In a surprising turn of events, emerging markets (EM) have demonstrated robust growth and outperformance against their US and European counterparts. This development comes after a period dominated by the "Make Europe Great Again" (MEGA) narrative in the early months of the year. The resurgence of EM is largely attributed to a combination of factors, including a weakening US dollar, a booming demand for AI-related hardware from key regions like Taiwan and Korea, and the resilience of sectors like gold and oil. This shift challenges the long-standing US-led market regime, prompting investors to re-evaluate diversification strategies amidst volatile global economic landscapes.

Emerging Markets Defy Expectations: A Detailed Analysis

Between January and April, the global financial discourse was heavily influenced by the "Make Europe Great Again" investment trend. Many analysts and market pundits speculated on Europe's potential ascendancy, discussing whether it was finally "Europe's moment" to shine in the global economy. This sentiment was widespread, often featured in macroeconomic analyses and financial podcasts, highlighting a perceived shift towards European market leadership.

However, the narrative took an unexpected turn as emerging markets began to show remarkable strength, outperforming both US and European equities. This unexpected rally in EM was driven by a confluence of economic factors. A significant contributor was the depreciation of the US dollar, making EM assets more attractive to international investors. Simultaneously, the burgeoning demand for Artificial Intelligence (AI) hardware, particularly from technology hubs in Taiwan and Korea, provided a substantial boost to EM economies, positioning them as crucial players in the global tech supply chain. The strong performance of commodities like gold and the resilience of oil prices further bolstered these markets, allowing them to thrive even as other economies faced challenges.

Despite this compelling performance, market observers remain cautious. The question lingers: Is this a definitive, long-term shift towards a non-US dominated investment era, or merely a cyclical rebound within an enduring US-centric global financial system? Historical precedents, such as the EM rally in 2017 that ultimately proved fleeting, serve as a reminder of the transient nature of such market shifts. The current situation thus presents a complex picture, urging investors to consider the nuances of market dynamics and the potential for both sustained growth and eventual reversals.

The recent outperformance of emerging markets offers a valuable lesson in the complexities of global investment. It underscores the importance of maintaining a truly diversified portfolio, capable of navigating unforeseen shifts in market regimes. The unpredictable nature of these transitions highlights the need for investors to look beyond conventional wisdom and continuously reassess where value and growth opportunities truly lie.

More Articles
Finance
Canadian Net REIT: Strong Performance Amidst Market Fluctuations
Canadian Net REIT has demonstrated remarkable resilience and growth in a volatile market, outperforming its international peers. Key drivers include its attractive valuations, strategic focus on Canada, and robust financial performance, highlighted by a 12% adjusted FFO growth in 2025. The company's strong leasing market, limited mortgage maturities, and full occupancy suggest continued positive momentum. While its valuation has matured, the low AFFO multiple and solid operational health present a compelling investment case, despite higher leverage.
By Michele FerreroMay 12, 2026
Finance
AbbVie Stock: Strong Fundamentals, Low Valuation, and Promising Future
AbbVie (ABBV) continues to be a compelling buy, characterized by strengthening fundamentals and a valuation that is nearing multiyear lows following recent stock underperformance. The company's Q1 net revenues saw a robust 12.4% year-over-year growth, indicating strong overall business activity despite some volatility within its Immunology portfolio. Management's confidence is further reinforced by raised full-year 2026 EPS guidance, projecting an underlying annual EPS growth of 14% after accounting for IPR&D and milestone impacts. Strategic investments, including a significant $1.4 billion campus in North Carolina, underscore AbbVie's commitment to long-term innovation and serve to mitigate potential political risks.
By Michele FerreroMay 12, 2026
Finance
Janus Henderson Forty Fund Q1 2026 Commentary
The Janus Henderson Forty Fund experienced a decline in the first quarter of 2026, underperforming the Russell 1000® Growth Index. This report analyzes the key contributors and detractors to its performance, including specific stock selections in consumer discretionary and industrials sectors, and highlights the fund's positioning for future growth, particularly in the context of the AI investment cycle.
By Michele FerreroMay 12, 2026
Finance
Brookfield Asset Management: A Prime Investment for Long-Term Growth and Stable Returns
Brookfield Asset Management (BAM) is currently undervalued, trading significantly below its peak, yet it's poised to surpass its ambitious long-term growth targets. With robust fee-bearing capital growth and a consistent dividend yield, BAM presents a compelling buy-the-dip opportunity for investors seeking both capital appreciation and steady income.
By Mariana MazzucatoMay 12, 2026
Finance
Understanding the Nuances of Share Premium Accounts in Corporate Finance
This article explores the concept of a share premium account, which records the excess amount paid by shareholders above a share's par value. It delves into its definition, practical applications such as covering equity expenses and issuing bonus shares, and how its balance can fluctuate with market conditions. The piece also explains its historical evolution and its role in a company's financial statements.
By Morgan HouselMay 12, 2026